SANDS CAPITAL VENTURES, LLC Holdings

SANDS CAPITAL VENTURES, LLC is an investment fund managing more than 344.07M US dollars. The largest holdings include DICE Therapeutics, UiPath and Nu Holdings Ltd.. In Q2 2022 the fund bought assets of total value of 25.01M US dollars and sold assets of total value of 12.09M US dollars.

$344.07M

portfolio value

+10.21%

quarter

-58.94%

1 year

SANDS CAPITAL VENTURES, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q4 2021	171110000	63294000
Q2 2022	25009000	12093000

SANDS CAPITAL VENTURES, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology DICE Therapeutics, Inc. Portfolio share: 18.56% Portfolio value: 63.86M Avg. open price: N/A Current price: $36.48 P/L: N/A N/A Q3 2021	share	18.56%	63.86M	N/A	$36.48	N/A	N/A Q3 2021
Software—Infrastructure UiPath Inc. Portfolio share: 13.97% Portfolio value: 48.06M Avg. open price: N/A Current price: $14.53 P/L: N/A N/A Q3 2021	share	13.97%	48.06M	N/A	$14.53	N/A	N/A Q3 2021
Banks—Diversified Nu Holdings Ltd. Portfolio share: 11.68% Portfolio value: 40.20M Avg. open price: N/A Current price: $4.46 P/L: N/A N/A Q4 2021	share	11.68%	40.20M	N/A	$4.46	N/A	N/A Q4 2021
Software—Application Snowflake Inc. Portfolio share: 10.60% Portfolio value: 36.47M Avg. open price: N/A Current price: $149.74 P/L: N/A Sold -32.21% shares Q4 2021	share	10.60%	36.47M	N/A	$149.74	N/A	Sold -32.21% shares Q4 2021
Biotechnology Acumen Pharmaceuticals, Inc. Portfolio share: 9.96% Portfolio value: 34.27M Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q3 2021	share	9.96%	34.27M	N/A	$5.6	N/A	N/A Q3 2021
Footwear & Accessories Samsara Luggage, Inc. Portfolio share: 9.51% Portfolio value: 32.73M Avg. open price: N/A Current price: $0.13 P/L: N/A N/A Q4 2021	share	9.51%	32.73M	N/A	$0.13	N/A	N/A Q4 2021
Internet Content & Information DoorDash, Inc. Portfolio share: 8.64% Portfolio value: 29.74M Avg. open price: N/A Current price: $55.19 P/L: N/A Sold -4.56% shares Q4 2021	share	8.64%	29.74M	N/A	$55.19	N/A	Sold -4.56% shares Q4 2021
Health Information Services 10x Genomics, Inc. Portfolio share: 3.99% Portfolio value: 13.72M Avg. open price: N/A Current price: $38.97 P/L: N/A N/A Q2 2022	share	3.99%	13.72M	N/A	$38.97	N/A	N/A Q2 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 3.85% Portfolio value: 13.24M Avg. open price: N/A Current price: $236.82 P/L: N/A Sold -65.94% shares Q3 2022	share	3.85%	13.24M	N/A	$236.82	N/A	Sold -65.94% shares Q3 2022
Diagnostics & Research Olink Holding AB (publ) Portfolio share: 2.49% Portfolio value: 8.56M Avg. open price: $17.66 Current price: $24.52 P/L: +38.84% Bought +65.80% shares Q2 2022	share	2.49%	8.56M	$17.66	$24.52	+38.84%	Bought +65.80% shares Q2 2022
Medical Devices 908 Devices Inc. Portfolio share: 1.56% Portfolio value: 5.37M Avg. open price: N/A Current price: $10.37 P/L: N/A N/A Q3 2021	share	1.56%	5.37M	N/A	$10.37	N/A	N/A Q3 2021
Biotechnology Tarsus Pharmaceuticals, Inc. Portfolio share: 1.29% Portfolio value: 4.45M Avg. open price: N/A Current price: $17.39 P/L: N/A N/A Q3 2021	share	1.29%	4.45M	N/A	$17.39	N/A	N/A Q3 2021
Medical Instruments & Supplies Repligen Corporation Portfolio share: 1.23% Portfolio value: 4.21M Avg. open price: N/A Current price: $186.05 P/L: N/A N/A Q3 2021	share	1.23%	4.21M	N/A	$186.05	N/A	N/A Q3 2021
Software—Infrastructure Samsara Inc. Portfolio share: 1.14% Portfolio value: 3.93M Avg. open price: N/A Current price: $11.9 P/L: N/A N/A Q4 2021	share	1.14%	3.93M	N/A	$11.9	N/A	N/A Q4 2021
Biotechnology Candel Therapeutics, Inc. Portfolio share: 0.74% Portfolio value: 2.54M Avg. open price: N/A Current price: $1.88 P/L: N/A N/A Q3 2021	share	0.74%	2.54M	N/A	$1.88	N/A	N/A Q3 2021
Biotechnology Taysha Gene Therapies, Inc. Portfolio share: 0.41% Portfolio value: 1.39M Avg. open price: N/A Current price: $2.35 P/L: N/A N/A Q3 2021	share	0.41%	1.39M	N/A	$2.35	N/A	N/A Q3 2021
Biotechnology Spruce Biosciences, Inc. Portfolio share: 0.31% Portfolio value: 1.07M Avg. open price: N/A Current price: $1.15 P/L: N/A N/A Q3 2021	share	0.31%	1.07M	N/A	$1.15	N/A	N/A Q3 2021
Biotechnology Absci Corporation Portfolio share: 0.05% Portfolio value: 181K Avg. open price: N/A Current price: $2.65 P/L: N/A N/A Q3 2021	share	0.05%	181K	N/A	$2.65	N/A	N/A Q3 2021
Biotechnology CinCor Pharma, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $12.29 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$12.29	N/A	Sold -100.00% shares Q3 2022

Showing TOP 19 SANDS CAPITAL VENTURES's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of SANDS CAPITAL VENTURES, LLC?

The biggest position of the SANDS CAPITAL VENTURES, LLC is DICE Therapeutics, Inc. (DICE) with 18.56% portfolio share worth of 63.86M US dollars.

Top 5 SANDS CAPITAL VENTURES's holdings represent 64.78% of the portfolio:

DICE Therapeutics, Inc. (DICE) – 18.56%
UiPath Inc. (PATH) – 13.97%
Nu Holdings Ltd. (NU) – 11.68%
Snowflake Inc. (SNOW) – 10.6%
Acumen Pharmaceuticals, Inc. (ABOS) – 9.96%

Who is the portfolio manager of SANDS CAPITAL VENTURES, LLC?

The portfolio manager of the SANDS CAPITAL VENTURES, LLC is .

What is the total asset value of the SANDS CAPITAL VENTURES, LLC portfolio?

SANDS CAPITAL VENTURES, LLC total asset value (portfolio value) is 344.07M US dollars.

Who is ?

is the portfolio manager of the SANDS CAPITAL VENTURES, LLC.

What is (SANDS CAPITAL VENTURES, LLC) fund performance?

SANDS CAPITAL VENTURES's quarterly performance is +10.21%, annualy -58.94%.

What is the SANDS CAPITAL VENTURES, LLC CIK?

SANDS CAPITAL VENTURES's Central Index Key is 0001846444 .